Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By Staff Reporters
***
***
Consulting firm McKinsey & Co has agreed to pay $230 million to resolve lawsuits by hundreds of U.S. local governments and school districts alleging it fueled an epidemic of opioid addiction through its work for bankrupt OxyContin maker Purdue Pharma and other drug companies.
CITE: https://www.r2library.com/Resource
***
Here is where the major benchmarks ended:
- The S&P 500 Index was up about 1 point (0.02%) at 4,274.51; the Dow Jones Industrial Average fell 69 points (0.20%) to 33,550.27; the NASDAQ gained 29 points (0.22%) to 13,092.85.
- The 10-year Treasury note yield was up 7 basis points at 4.613%.
- CBOE Volatility Index (VIX) fell half a point to 18.42.
Energy stocks were among the best performers Wednesday, with the S&P 500 Energy Sector rising 2.5%. The U.S. Dollar Index (DXY), which has been rising since July as investors digested the likelihood of “higher-for-longer” interest rates, remained at its highest level so far this year.
***
COMMENTS APPRECIATED
Thank You
***
***
Share this:
Filed under: "Ask-an-Advisor", "Doctors Only", Alerts Sign-Up, Drugs and Pharma, Experts Invited, Financial Planning, Funding Basics, Health Economics, Healthcare Finance, Investing | Tagged: addiction, CBOE, DJIA, DOW, drugsm drug abuse addiction, DXY, McKinsey & Co, narcotics, NSDAQ, opioid, Oxycodone, oxycontin, Purdue, Purdue Pharma, Russell 2000, S&P 500, S&P 500 Energy Sector, VIX | Leave a comment »
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 